In March, 1,521 total Ozempic Lawsuits were filed
less frequent, larger meals
FDA Guidelines for GLP-1 Medications The FDA has clear criteria for prescribing GLP-1 medications for chronic weight management: a BMI of 30 or higher, or a BMI of 27 with at least one weight-related comorbidity
Wegovy (semaglutide) Prescribing Information
Mannitol (23.2 mg in 0.5 mL): Used primarily as a tonicity agent, mannitol helps adjust the osmolarity of the injection solution to be compatible with body fluids
GLP-1 Receptor Agonists (GLP-1 RAs):Primary mechanism: Mimicking the GLP-1 hormone to regulate appetite, blood sugar, and potentially influencing brain reward pathways.Common side effects: Nausea, vomiting, diarrhea, constipation (often gastrointestinal).Potential benefits for mood: Indirect effects through weight management, reduced "food noise," and possible anti-inflammatory actions